The Rosen Law Firm, a global investor rights law firm, announced a September 30, 2025, deadline for investors who purchased Novo Nordisk A/S (NYSE: NVO) securities between May 7, 2025, and July 28, 2025. Investors who meet these criteria may be entitled to compensation. The firm emphasizes that participation does not require any upfront fees.
This class-action lawsuit alleges that Novo Nordisk misled investors about its growth potential. Specifically, the suit claims the company provided overly optimistic statements while concealing negative information regarding the impact of market factors on its products. The firm contends that the company downplayed potential challenges and overstated its ability to penetrate specific markets.
The lawsuit further claims that when the true situation became public, investors experienced financial losses. Rosen Law Firm is encouraging investors to consider their options before the lead plaintiff deadline.
The firm highlights its extensive experience in securities class-action litigation. They cite their track record, including a significant settlement achieved against a Chinese company, and their consistent high rankings in the field. Rosen Law Firm emphasizes its resources and expertise, urging investors to select qualified counsel.
Investors interested in serving as lead plaintiff must act before the September 30th deadline. The lead plaintiff will represent other class members in managing the legal proceedings. However, Rosen Law Firm clarifies that participation in any potential recovery is not contingent upon becoming the lead plaintiff. Investors can choose to remain absent class members.
Rosen Law Firm is available to provide further information to interested investors. They can be reached by phone, email, or through their website. The firm cautions that prior results do not guarantee similar outcomes in future cases. The information provided constitutes attorney advertising.
The firm is based in New York City and has a long history of representing investors globally in securities class actions and shareholder derivative litigation. Their attorneys have received numerous accolades and recognitions within the legal profession. The firm has secured hundreds of millions of dollars in recoveries for investors in previous cases.
Related
